Scientific Evidence and Articles

Original on Transparent.png

Over 200 Scientists & Doctors Call For Increased Vitamin D Use To Combat COVID-19

Scientific evidence indicates vitamin D reduces infections & deaths

Vitamin D modulates thousands of genes and many aspects of immune function, both innate and adaptive. The scientific evidence1 shows that:

  • Higher vitamin D blood levels are associated with lower rates of SARS-CoV-2 infection.

  • Higher D levels are associated with lower risk of a severe case (hospitalization, ICU, or death).

  • Intervention studies (including RCTs) indicate that vitamin D can be a very effective treatment.

  • Many papers reveal several biological mechanisms by which vitamin D influences COVID-19.

  • Causal inference modelling, Hill’s criteria, the intervention studies & the biological mechanisms indicate that vitamin D’s influence on COVID-19 is very likely causal, not just correlation.

 
 

Protective Role of Combined Polyphenols and Micronutrients against Influenza A Virus and SARS-CoV-2 Infection In Vitro

by Marta De Angelis 1, David Della-Morte 2,3,4,*, Gabriele Buttinelli 5, Angela Di Martino 5, Francesca Pacifici 2, Paola Checconi 3, Luigina Ambrosio 5, Paola Stefanelli 5, Anna Teresa Palamara 1, Enrico Garaci 3, Camillo Ricordi 6 and Lucia Nencioni 1,*

1 Laboratory Affiliated to Istituto Pasteur-Fondazione Cenci Bolognetti, Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy

2 Department of Systems Medicine, University of Rome “Tor Vergata”, 00133 Rome, Italy

3 Department of Human Sciences and Quality of Life Promotion, San Raffaele Roma Open University, IRCCS San Raffaele Roma, 00166 Rome, Italy

4 Department of Neurology and Evelyn F. McKnight Brain Institute, Miller School of Medicine, University of Miami, Miami, FL 33136, USA

5 Department of Infectious Diseases, Istituto Superiore di Sanità, 00161 Rome, Italy

6 Cell Transplant Center, Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL 33136, USA

  • Authors to whom correspondence should be addressed.

POSEIDON study: a pilot, safety and feasibility trial of high-dose omega3 fatty acids and high-dose cholecalciferol supplementaton in type 1 diabetes

Authors:

Baidal D. A., Sanchez J., Alejandro R., Blaschke C. E., Hirani K., Matheson D. L., Messinger S., Pugliese A., Rafin L. E., Roque L. A., Vera Ortz J. M. and Ricordi C.

Vitamin D and Marine n-3 Fatty Acid Supplementation and Prevention of Autoimmune Disease in the VITAL Randomized Controlled Trial

Authors:

Jill Hahn, Nancy Cook, Erik Alexander, Sonia Friedman, Vadim Bubes, Joseph Walter, Gregory Kotler, I-Min Lee, JoAnn Manson and Karen Costenbader, 1Harvard T.H. Chan School of Public Health, Boston, MA, Brigham and Womens' Hospital, Boston, MA, Brigham and Women's Hospital/ Harvard Medical School, Boston, MA, Brigham and Women's Hospital, Belmont, MA

Role of Exercise and Natural Protective Substances on Sirtuin Activation

Authors:

Camillo Ricordi1,2*, Silvano Zanuso3,4*, Marco Menichelli2,5

Novel Insights Into Immune Systems of Bats

Authors:

Arinjay Banerjee, Michelle L. Baker, Kirsten Kulcsar, Vikram Misra, Raina Plowright and Karen Mossman

A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19

Authors:

Oliver J McElvaneya, Brian D Hobbsc, Dandi Qiaoc, Oisín F McElvaneya, Matthew Mollc,Natalie L McEvoye, Jennifer Clarkeb, Eoin O’Connorb, Sean Walsh, Michael H Choc, Gerard F Curleyb, Noel G McElvaneya

Indietro

Articles